Effective low-dose escalation of indocyanine green for near-infrared fluorescent sentinel lymph node mapping in melanoma

Annals of Surgical Oncology

Volumn 20, Issue 7, 2013, Pages 2357-2363

  Gilmore, Denis M ^a,b   Khullar, Onkar V ^b   Gioux, Sylvain ^b   Stockdale, Alan ^b   Frangioni, John V ^b   Colson, Yolonda L ^a   Russell, Sara E ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; INDOCYANINE GREEN; NANOCOLLOID TC 99M; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; FEASIBILITY STUDY; FEMALE; FLUORESCENCE IMAGING; HUMAN; LYMPHOSCINTIGRAPHY; MALE; MELANOMA; NEAR INFRARED FLUORESCENCE IMAGING; PREOPERATIVE PERIOD; RISK ASSESSMENT; SENTINEL LYMPH NODE BIOPSY; SENTINEL LYMPH NODE METASTASIS;

ADULT; AGED; COLORING AGENTS; FEMALE; FLUORESCENCE; HUMANS; INDOCYANINE GREEN; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; MITOTIC INDEX; RADIOPHARMACEUTICALS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SPECTROSCOPY, NEAR-INFRARED; TECHNETIUM TC 99M AGGREGATED ALBUMIN;

EID: 84878868808     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-013-2905-x     Document Type: Article

References (36)

1. Balch CM, Soong SJ, Ross MI, et al. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol. 2000;7:87-97. (Pubitemid 30164676)
2. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on cancer staging system for cutaneous melanoma. J Clin Oncol. 2001;19:3635-48. (Pubitemid 32786276)
3. Manola J, Atkins M, Ibrahim J, Kirkwood J. Prognostic factors in metastatic melanoma: a pooled analysis of Eastern Cooperative Oncology Group trials J Clin Oncol. 2000;18:3782-93.
4. Tsao H, Cosimi AB, Sober AJ. Ultra-late recurrence (15 years or longer) of cutaneous melanoma. Cancer. 1997;79:2361-70. (Pubitemid 27251019)
5. Morton DL, Wanek L, Nizze JA, Elashoff RM, Wong JH. Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic. Ann Surg. 1991;214:499-501.
6. Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol. 1999;17:976-83. (Pubitemid 29109331)
7. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392-9.
8. Chen SL, Iddings DM, Scheri RP, Bilchik AJ. Lymphatic mapping and sentinel node analysis: current concepts and applications. CA Cancer J Clin. 2006;56:292-309. (Pubitemid 44527491)
9. Veronesi U, Adamus J, Bandiera DC, et al. Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer. 1982;49:2420-30. (Pubitemid 12122934)
10. Balch CM, Soong SJ, Bartolucci AA, et al. Efficacy of an elective regional lymph node dissection of 1-4 mm thick melanomas for patients 60 years of age and younger. Ann Surg. 1996;224:255-63. (Pubitemid 26307468)
11. Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355:1307-17. (Pubitemid 44465459)
12. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392-9.
13. Morton DL, Cochran AJ, Thompson JF, et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg. 2005;242:302-11.
14. Morton DL, Cochran AJ, Thompson JF, et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg. 2005;242:302-11.
15. Chao C, Wong SL, Edwards MJ, et al. Sentinel lymph node biopsy for head and neck melanomas. Ann Surg Oncol. 2003;10:21-6.
16. Carlson GW, Page AJ, Cohen C, et al. Regional recurrence after negative sentinel lymph node biopsy for melanoma. Ann Surg. 2008;248:378-86.
17. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392-9.
18. Mariani G, Moresco L, Viale G, et al. Radioguided sentinel lymph node biopsy in breast cancer surgery. J Nucl Med. 2001;42:1198-215. (Pubitemid 32717839)
19. Gioux S, Choi HS, Frangioni JV. Image-guided surgery using invisible near-infrared light: fundamentals of clinical translation. Mol Imaging. 2010;9:237-55.
20. Hojo T, Nagao T, Kikuyama M, Akashi S, Kinoshita T. Evaluation of sentinel node biopsy by combined fluorescent and dye method and lymph flow for breast cancer. Breast. 2010;19:210-3.
21. Mieog JS, Troyan SL, Hutteman M, et al. Towards optimization of imaging system and lymphatic tracer for near-infrared fluorescent sentinel lymph node mapping in breast cancer. Ann Surg Oncol. 2011;18:2483-91.
22. Troyan SL, Kianzad V, Gibbs-Strauss SL, et al. The FLARE intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in breast cancer sentinel lymph node mapping. Ann Surg Oncol. 2009;16:2943-52.
23. Murawa D, Hirche C, Dresel S, et al. Sentinel lymph node biopsy in breast cancer guided by indocyanine green fluorescence. Br J Surg. 2009;96:1289-94.
24. Crane LM, Themelis G, Pleijhuis RG, et al. Intraoperative multispectral fluorescence imaging for the detection of the sentinel lymph node in cervical cancer: a novel concept. Mol Imaging Biol. 2011;13:1043-9.
25. Schaafsma BE, Mieog JSD, Hutteman M, et al. The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery. J Surg Oncol. 2011;104:323-32.
26. Fujisawa Y, Nakamura Y, Kawachi Y, et al. A custom-made, low-cost intraoperative fluorescence navigation system with indocyanine green for sentinel lymph node biopsy in skin cancer. Dermatology. 2011;222:261-8.
27. Fujiwara M, Mizukami T, Suzuki A, et al. Sentinel lymph node detection in skin cancer patients using real-time fluorescence navigation with indocyanine green: preliminary experience. J Plast Reconstr Aesthet Surg. 2009;62:e373-e378.
28. Tanaka R, Nakashima K, Fujimoto W. Sentinel lymph node detection in skin cancer using fluorescence navigation with indocyanine green. J Dermatol. 2009;36:468-70.
29. Mizukami T, Fujiwara M, Suzuki A, et al. Sentinel lymph node detection by indocyanine green fluorescence imaging in skin cancer patients: technical refinement. Open Surg Oncol J. 2010;2:57-61.
30. Fujisawa, Y, Nakamura Y, Otsuka F, et al. Indocyanine green fluorescence-navigated sentinel node biopsy showed higher sensitivity than the radioisotope or blue dye method, which may help to reduce false-negative cases in skin cancer. J Surg Oncol. 2012;106:41-5.
31. Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001;19:3622-34. (Pubitemid 32786275)
32. Gussack GS, Reintgen D, Cox E, et al. Cutaneous melanoma of the head and neck: a review of 399 cases. Arch Otolaryngol. 1983;109:803-8. (Pubitemid 14232368)
33. Fisher SR. Cutaneous malignant melanoma of the head and neck. Laryngoscope. 1989;8:822-36. (Pubitemid 19199965)
34. Carlson GW, Murray DR, Greenlee R, et al. Management of malignant melanoma of the head and neck using dynamic lymphoscintigraphy and gamma probe-guided sentinel lymph node biopsy. Arch Otolaryngol Head Neck Surg. 2000;126:433-7. (Pubitemid 30140406)
35. O'Brien CJ, Uren RF, Thompson JF, et al. Prediction of potential metastatic sites in cutaneous head and neck melanoma using lymphoscintigraphy. Am J Surg. 1995;170:461-6.
36. McMasters KM, Noyes RD, Reintgen DS, et al. Lessons learned from the Sunbelt Melanoma Trial. J Surg Oncol. 2004;86:212-23. (Pubitemid 38880288)